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Background: Dengue fever is a common mosquito borne viral fever in South Asia, which causes significant
morbidity and mortality. Dengue fever is well known to involve the liver, especially in dengue hemorrhagic fever.
The hepatic involvement is usually that of a mild hepatitis with transaminase derangement without jaundice. In
cases of dengue hemorrhagic fever where shock has ensued, a severe hepatitis with gross derangements of
transaminases and bilirubin may occur. These are two rare cases of adult patients with dengue hemorrhagic fever
presenting with a cholestatic type of jaundice.
Case presentation: This case report describes two female patients aged 30 and 46 years who presented with fever,
icterus and biochemical analysis revealed cholestatic jaundice. Evolution of the clinical picture and dropping
platelets prompted serological investigations in the form of dengue non-structural protein 1 antigen and dengue
immunoglobulin M which confirmed acute dengue infection.
Conclusion: These cases highlight the importance of considering dengue fever as a differential diagnosis even in
the presence of a cholestatic jaundice, especially in countries where dengue fever is endemic, and in travelers
returning from dengue endemic countries. The early diagnosis of dengue fever and timely institution of supportive
fluid management is essential to prevent morbidity and mortality.
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Dengue fever is the commonest mosquito born viral ill-
ness known to man, with cases exceeding 2.2 million in
2010 [1]. Dengue viruses (DENV) are classified into four
serotypes (DENV-1, 2, 3 and 4). Infection may be clinically
asymptomatic or give rise to an undifferentiated fever,
dengue fever (DF), dengue haemorrhagic fever (DHF) or
dengue shock syndrome (DSS) [2]. One third of the world
population is at risk and with outbreaks occurring in cyc-
lical epidemics in Asia, Sri Lanka is at a greater risk as it is
a country naturally endemic to dengue [2-4]. An increas-
ing number of patients whom present with the clinical
picture of fever, myalgia and arthralgia, can evolve into
dengue hemorrhagic fever with plasma leakage, which if
not properly managed could very well progress to* Correspondence: yudhishdran@yahoo.com
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article, unless otherwise stated.worsening organ involvement with dengue shock. Liver in-
volvement in dengue fever is typically that of a hepatitis
which ranges from mild derangement of liver enzymes
to fulminant hepatitis, with manifestations ranging from
hypochondrial-pain, hepatomegaly and rarely even jaun-
dice [5]. We describe two patients who had in addition to
fever had cholestatic jaundice as an initial presenting
symptom which was due to dengue infection.
Case presentation
1st case vignette
A 30 year old South-Asian female presented with 5 day
history of high fever associated with severe myalgia,
headache and yellowish discoloration of the skin. There
was no history of contact with muddy water, alcohol
consumption, or use of any drugs including antibiotics,
anti-pyretics (acetaminophen) or antiemetics. Further-
more history of blood transfusion, sexual promiscuity or
any other high risk behavior could not be elicited. Shentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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general examination revealed she was febrile and icteric but
had no conjunctival hemorrhage, pallor, lymphadenopathy,
rashes or scratch marks. The respiratory system was unre-
markable and the abdominal examination did not elicit
right hypochondrial tenderness, palpable gall bladder or ab-
dominal guarding. The cardiovascular examination was
normal and she had an initial blood pressure of 90 mmHg
systole and 60 mmHg diastole, without a postural drop.
She was conscious, alert, well oriented and nervous system
examination was otherwise unremarkable.
The initial complete blood count revealed throm-
bocytopenia with a platelet count of 69 × 109/L (150–
450), a normal white blood cell count (WBC) of 10.4 ×
109/L (4–11) with a predominance of lymphocytes
(55%) and a hemoglobin of 11.0 g/dL (11–17) . The
blood picture mirrored the whole blood analysis and
showed only thrombocytopenia, there was no neutro-
phil left shift or toxic granules and the red cell indices
were normal. Liver functions showed a mildly elevated
aspartate transaminase(AST) and alanine transaminase
(ALT) which were 80 U/L(0–40) and 38 U/L (0–35 ) re-
spectively with an elevated alkaline phosphatase(ALP)
value of 450 U/L (100–360). Serum direct and total bili-
rubin levels were elevated at 6 mg/dL (0–0.3) and
9.1 mg/dL (0.3-1.9) respectively. Serum albumin was
found to be reduced with a value of 2.3 g/dL (3.5 -5.5),
with a normal international normalized ratio (INR). The
renal functions were within normal reference range.
The C- reactive protein (CRP) and erythrocyte sedimen-
tation rate (ESR) were also within normal parameters. The
following day the platelet count continued to drop and her
jaundice deepened. A positive dengue non- structural pro-
tein1antigen test (NS1) and a positive dengue IgM anti-
body ELISA test on day 6 confirmed the clinical suspicion
and diagnosis of dengue fever. Hepatitis B surface antigen,
hepatitis C antibody, hepatitis A and E antibodies, Ebstein
Barr Virus antibody and a retroviral screening were all
negative. Leptospira microscopic agglutination test (Lepto
MAT) titres were insignificant at 1:200 on day 6 and the
titre value remained unchanged when the repeat test was
performed on day 12 of the illness (a four -fold rise in titre
or a high titre >1:800 is the gold standard for diagnosis).
Blood cultures remained repeatedly negative.
The platelet count continued to drop rapidly in the fol-
lowing days reaching the lowest nadir value of 3 × 109/L
(150–450) with rising alkaline phosphatase and biliru-
bin levels (Table 1). On day 6 of the illness the patient
became afebrile. As per the local guidelines and WHO
dengue guidelines on management of critical phase of
dengue hemorrhagic fever, she was maintained on a
fluid regimen tailored to her body weight, with strict
monitoring of the blood pressure, pulse pressure, heart
rate and urine output.On day 7 the patient became mildly tachypnoeic, and
examination revealed reduced air entry in the right lung
base which was stony dull to percussion and deep ic-
terus, further abdominal examination elicited a small
shifting dullness, signifying ascites. An ultrasound scan
was done and confirmed a small right sided pleural effu-
sion, an enlarged liver of 16 cm, without intra or extra
hepatic bile duct dilatation, a thickened gall bladder wall
of 7 mm in the absence of any gall stones and a sono-
graphic Murphy’s sign could not be elicited. Mild ascites
was also noted. The blood pressure and urine output
were maintained. A packed cell volume was done and
showed only a mild rise. The fluid regimen was contin-
ued as per guidance, giving adequate fluids to maintain
blood pressure and urine output.
On day 9 of the illness, the patient’s clinical status and
jaundice improved. Serial complete blood counts showed
rising platelet counts. Similarly liver function tests re-
vealed normalizing alkaline phosphatase and bilirubin
levels. The patient was discharged on the 15th day of illness
with normal cell counts and liver function parameters.
2nd case vignette
A 46 year old previously well South-Asian female, pre-
sented with six days of high fever, myalgia and jaundice.
She too denied any history of contact with muddy water,
recent drug usage, blood transfusion or any high risk be-
havior. On examination, she appeared ill, febrile to touch
and deeply jaundiced. Abdominal examination revealed
a mildly tender and firm hepatomegaly. The gallbladder
was not palpable nor was there guarding or a positive
Murphy’s sign. The respiratory system examination re-
vealed reduced air entry on auscultation and stony dull-
ness to percussion in the base of the right lung. The
cardiovascular examination was unremarkable, with a
blood pressure of 100mmHg systole and 70 mmHg with-
out a postural drop. The nervous system examination was
normal.
Whole blood analysis on presentation demonstrated
thrombocytopenia with a platelet count of 10 × 109/L
(150–450) and a lymphocytic predominant (51%) white
cell count of 7.8 × 109/L (4–11) with a haemoglobin
value of 11.6 g/dl with a packed cell volume of 34%. The
liver enzymes were elevated with the AST more than the
ALT which were 242 U/L (0–40) and 120 U/L(0–35) re-
spectively. The alkaline phosphatase was mildly elevated
with a value of 400 U/L (100 – 360), with a high direct
bilirubin fraction of 12 μmol/L (0–3.4) and total biliru-
bin of 23 μmol/L (5–21). Albumin was found mildly re-
duced at 31 g/L (36–48). The INR was normal. The
renal functions were normal. The ultrasound scan of the
abdomen and chest confirmed an enlarged liver, with a
cranio-caudal length of 16 cm. The gallbladder wall was
thickened and measured 6 mm, a negative sonographic












Pt 1 Pt 2 Pt 1 Pt 2 Pt 1 Pt 2 Pt 1 Pt 2 Pt 1 Pt 2 Pt 1 Pt 2 Pt 1 Pt 2
5 80 38 450 9.1 6 69 31.1%
6 100 242 52 120 490 400 10.6 23 7.8 12 30 10 32% 34%
8 116 230 56 98 598 412 12.6 22 9.6 6 3 5 35% 34.2%
9 88 160 50 83 448 625 11.6 17.7 8.8 6.2 20 17 33% 30.1%
10 127 78 631 18 8 31 29.9%
11 70 44 368 4.8 3.0 55 62 32% 29.9%
12 88 45 378 16 3 128 30.8%
13 66 40 300 2 1.4 108 32%
15 60 40 260 0.8 0.2 166 32%
(Day- day of the illness, AST- aspartate transaminase, ALT- alanine transaminase, ALP-alkaline phosphatase, T.Bilirubin- total bilirubin, D.Bilirubin- direct bilirubin,
PCV-packed cell volume, Pt 1- Patient discussed in case vignette 1, Pt 2- Patient discussed in case vignette 2).
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ized. Leakage was confirmed as there was mild ascites
and a pleural effusion in the right hemithorax. The ESR
was 19 mm for the first hour and the CRP was mildly ele-
vated with a value of 7 mg/L (0.0 – 5.0). The dengue IgM
antibody was positive. A Lepto MAT was performed twice
on day 7 and day 11 of the illness, and showed a titre of
1:400 (a four -fold rise in titre or a high titre >1:800 is the
gold standard for diagnosis) without further rise. A hepa-
titis screen was performed and was found negative. EBV
antibody was also negative. This patient was similarly
managed with a fluid regimen tailored to her body weight
as per guidance, with strict monitoring of hemodynamic
parameters and urine output.
The platelet count continued to drop reaching a nadir
of 5 × 109/L (150–450) on day 8 of the illness, and sub-
sequently began to rise. The alkaline phosphatase and
bilirubin continued to rise till day 10 of the illness, after
which the liver functions began to normalize (Table 1).
The patient was discharged on day 12 of the illness, being
afebrile for 4 days with a platelet count of 128 × 109/L
(150–450) and a near normal bilirubin level.
Discussion
Dengue infection is usually associated with liver involve-
ment, and this is more frequently seen among women,
patients with a primary infection and in those with DHF
[5]. This claim is reinforced as hepatomegaly is frequent
and commoner in patients with DHF than in those with
DF [6,7] as are transaminase levels higher in DHF/DSS
than in DF, though the rise is transient and tend to
normalize on recovery [6,8]. In dengue infections, eleva-
tion in serum AST is greater than ALT levels, similar to
the pattern seen with alcoholic hepatitis [9]. Though
other indicators of liver function such as serum bilirubin
and alkaline phosphatase can also be deranged their in-
cidence is relatively less in comparison to the often seenrise in transaminase levels (7.2%, 16.3% and 93.3% respect-
fully) [10]. The causative dengue serotype is a also a factor
with a greater degree of hepatic involvement in infections
with DENV-3 and DENV-4 [11]. Furthermore there is a
suggested correlation between acetaminophen administra-
tion for fever, and the degree of liver damage [12].
The exact pathogenesis of liver injury in dengue is yet
to be determined. The liver cells may be damaged
through one or more of the following mechanisms: dir-
ect cytopathic effect of the virus, killing of virus-infected
cells by the host immune response- the activated lym-
phocytes, antibodies against dengue proteins cross-
reacting with host cell proteins and as a nonspecific
effect of shock [13,14]. Another form of hepatic involve-
ment which is known to occur in dengue fever is an
acalculous cholecystitis. However these patients will
have the characteristic right hypochondrial tenderness
and a positive Murphy’s sign with the ultrasound con-
firming the thickened gallbladder and elicitation of a
sonographic Murphy’s sign as well. Furthermore eleva-
tions in total bilirubin and alkaline phosphatase are not
common in cholecystitis as the inflammation is re-
stricted to the gall bladder [15,16]. Jaundice is seen in
fulminant hepatitis secondary to dengue [17], but neither
of our patients progressed to this stage of hepatic dys-
function. The development of bilirubinemia and chole-
static jaundice, without fulminant hepatitis is thought to
occur due to ongoing inflammatory process of dengue
infection, which can effectively reduce the diameter of
the lumen of the biliary canaliculus, causing obstruction.
This can be attributed directly or indirectly to the effects
of the dengue virus [5].
Alternate causes of cholestatic jaundice should be consid-
ered. Ultra-sonographic imaging in our patients failed to
demonstrate gall stones, and furthermore the normalizing
bilirubin with the recession of jaundice made a sinister
cause like carcinoma of the head of the pancreas unlikely.
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structive pattern of jaundice, but the clinical picture seen in
acute/liver phase of the infection is different from the char-
acteristic symptoms and biochemical derangement to that
of dengue, additionally it is the chronic/biliary phase that
classically produces jaundice in Fasciola Hepatica infection
[18]. Though exclusion would have been useful, jaundice
was unlikely to be attributable to a liver fluke. Our patients
had jaundice, but neither of them complained of preceding
or associated pruritus. Though known to occur, the fre-
quency and intensity of pruritus has poor correlation to the
severity of jaundice, and is more commoner in chronic cho-
lestatic jaundice than in obstructive variant, and even less
so when the obstructive pathology is benign . Pruritus can
also be absent [19]. Pale colored clay stools, another feature
of obstructive jaundice was also absent, and this most likely
due to that fact the obstruction was partial. Serological
diagnosis of dengue was confirmed using dengue IgM and
NS1 as they were positive. Though NS1 is commonly an
early indicator it can be detectable even late in the disease
and though not the ideal choice, it may be useful even in
late presenters considering availability of investigational fa-
cilities [20,21]. Overall the clinical picture, serological diag-
nosis and rapid improvement of jaundice upon clinical
recovery favored cholestatic jaundice being secondary to
dengue infection in both our patients.
Cholestatic jaundice in otherwise uncomplicated DF/
DHF has been reported only scarcely in medical litera-
ture, once in a neonate with dengue fever [22] and two
other adults [5]. We report this rare phenomenon in
two cases of adult patients with dengue haemorrhagic
fever. Further studies are required into the incidence
and exact mechanism of hepatic damage giving rise to
the observed clinical picture of cholestasis in dengue
haemorrhagic fever, which is probably a poorly appreci-
ated hepatic manifestation.
Conclusion
These cases highlight that in addition to deranged liver en-
zymes, cholestatic pattern of jaundice may be an under
recognized clinical manifestation of dengue fever. A high
suspicion of dengue should be present when other sup-
portive clinical and laboratory criteria are present in
addition to that of jaundice. Countries that are endemic to
dengue and regions that have epidemic outbreaks should
be vary of the different presentations that may mask
dengue fever.Consent
Written informed consent was obtained from both pa-
tients for publication of this Case Report. Copies of the
written consent are available for review by the Editor-in-
Chief of this journal.Competing interests
The authors declare that they have no competing interests.Author’s contributions
JY carried out the literature search and drafted the manuscript; AR and RN did
critical revision for important intellectual content in the manuscript and gave
the final approval of the version to be published; SJ helped substantially in
literature search and drafting the manuscript. All authors provided clinical care
for the patient and have read and approved the final manuscript.Acknowledgements
The authors thank the department of biochemistry of the National Hospital
of Sri Lanka and the Medical Research Institute for providing help in the
diagnosis and management of the patients described in the case report.
Author details
1Department of Medicine (ward 56), National Hospital of Sri Lanka, Regent
street, Colombo, Sri Lanka. 2Department of Medicine, National Hospital of Sri
Lanka, Regent street, Colombo, Sri Lanka. 3Department of medicine,
Colombo South Teaching Hospital, Colombo, Sri Lanka.
Received: 19 December 2013 Accepted: 18 August 2014
Published: 26 August 2014References
1. Dengue and severe dengue-Fact sheet N°117. [http://www.who.int/
mediacentre/factsheets/fs117/en/]
2. Gibbons RV, Vaughn DW: Dengue: an escalating problem. BMJ 2002,
324:1563–1566.
3. Sirisena PD, Noordeen F: Evolution of dengue in Sri Lanka-changes in the
virus, vector, and climate. Int J Infect Dis 2014, 19:6–12.
4. Ooi EE, Gubler DJ: Dengue in Southeast Asia: epidemiological
characteristics and strategic challenges in disease prevention. Cad Saude
Publica 2009, 25(Suppl 1):S115–S124.
5. de Souza LJ, Nogueira RM, Soares LC, Soares CE, Ribas BF, Alves FP, Vieira
FR, Pessanha FE: The impact of dengue on liver function as evaluated by
aminotransferase levels. Braz J Infect Dis 2007, 11:407–410.
6. Wahid SF, Sanusi S, Zawawi MM, Ali RA: A comparison of the pattern of
liver involvement in dengue hemorrhagic fever with classic dengue
fever. Southeast Asian J Trop Med Public Health 2000, 31:259–263.
7. Shah GS, Islam S, Das BK: Clinical and laboratory profile of dengue
infection in children. Kathmandu Univ Med J (KUMJ) 2006, 4:40–43.
8. Mohan B, Patwari AK, Anand VK: Hepatic dysfunction in childhood
dengue infection. J Trop Pediatr 2000, 46:40–43.
9. Chongsrisawat V, Hutagalung Y, Poovorawan Y: Liver function test results
and outcomes in children with acute liver failure due to dengue
infection. Southeast Asian J Trop Med Public Health 2009, 40:47–53.
10. Kuo CH, Tai DI, Chang-Chien CS, Lan CK, Chiou SS, Liaw YF: Liver biochemical
tests and dengue fever. Am J Trop Med Hyg 1992, 47:265–270.
11. Kalayanarooj S, Nimmannitya S: Clinical presentations of dengue
hemorrhagic fever in infants compared to children. J Med Assoc Thai
2003, 86 Suppl 3:S673–S680.
12. Clayton TA, Lindon JC, Cloarec O, Antti H, Charuel C, Hanton G, Provost JP, Le
Net JL, Baker D, Walley RJ, Everett JR, Nicholson JK: Pharmaco-metabonomic
phenotyping and personalized drug treatment. Nature 2006, 440:1073–1077.
13. Guzman MG, Kouri G: Dengue: an update. Lancet Infect Dis 2002, 2:33–42.
14. Smith DR, Khakpoor A: Involvement of the liver in dengue infections.
Dengue Bull 2009, 33:75–86.
15. Sharma N, Mahi S, Bhalla A, Singh V, Varma S, Ratho RK: Dengue fever
related acalculous cholecystitis in a North Indian tertiary care hospital.
J Gastroenterol Hepatol 2006, 21:664–667.
16. Bhatty S, Shaikh NA, Fatima M, Sumbhuani AK: Acute acalculous
cholecystitis in dengue fever. J Pak Med Assoc 2009, 59:519–521.
17. Roy A, Sarkar D, Chakraborty S, Chaudhuri J, Ghosh P: Profile of hepatic
involvement by dengue virus in dengue infected children. N Am J Med
Sci 2013, 5:480–485.
18. Moghadami M, Mardani M: Fasciola hepatica: a cause of obstructive
jaundice in an elderly man from Iran. Saudi J Gastroenterol 2008,
14:208–210.
Yudhishdran et al. BMC Research Notes 2014, 7:568 Page 5 of 5
http://www.biomedcentral.com/1756-0500/7/56819. Kremer AE, Oude Elferink RP, Beuers U: Pathophysiology and current
management of pruritus in liver disease. Clinic Res Hepatol Gastroenterol
2011, 35:89–97.
20. Alcon S, Talarmin A, Debruyne M, Falconar A, Deubel V, Flamand M:
Enzyme-linked immunosorbent assay specific to Dengue virus type 1
nonstructural protein NS1 reveals circulation of the antigen in the blood
during the acute phase of disease in patients experiencing primary or
secondary infections. J Clin Microbiol 2002, 40:376–381.
21. Singh MP, Goyal K, Ratho RK: Nonstructural protein NS1: giving a new
structure to dengue diagnosis. J Clin Microbiol 2010, 48:4688. author reply
4688–4689.
22. Kumar A, Taksande A, Vilhekar K, Jain M: Prolonged neonatal cholestasis: a
rare manifestation of dengue fever. Internet J Pediatr Neonatology 2007,
9(1). Available from: http://ispub.com/IJPN/9/1/3528.
doi:10.1186/1756-0500-7-568
Cite this article as: Yudhishdran et al.: Dengue haemorrhagic fever
presenting with cholestatic hepatitis: two case reports and a review of
literature. BMC Research Notes 2014 7:568.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
